These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32274759)

  • 1. The Interplay Between Proteostasis Systems and Parkinson's Disease.
    Lázaro DF; Outeiro TF
    Adv Exp Med Biol; 2020; 1233():223-236. PubMed ID: 32274759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein trapping leads to altered synaptic proteostasis in synucleinopathies.
    Santos PI; Outeiro TF
    FEBS J; 2020 Dec; 287(24):5294-5303. PubMed ID: 32400966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
    Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
    J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.
    Stojkovska I; Wani WY; Zunke F; Belur NR; Pavlenko EA; Mwenda N; Sharma K; Francelle L; Mazzulli JR
    Neuron; 2022 Feb; 110(3):436-451.e11. PubMed ID: 34793693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders.
    Ugras S; Daniels MJ; Fazelinia H; Gould NS; Yocum AK; Luk KC; Luna E; Ding H; McKennan C; Seeholzer S; Martinez D; Evans P; Brown D; Duda JE; Ischiropoulos H
    EBioMedicine; 2018 May; 31():307-319. PubMed ID: 29759483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.
    Skibinski G; Hwang V; Ando DM; Daub A; Lee AK; Ravisankar A; Modan S; Finucane MM; Shaby BA; Finkbeiner S
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1165-1170. PubMed ID: 28028237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Poly)phenol-digested metabolites modulate alpha-synuclein toxicity by regulating proteostasis.
    Macedo D; Jardim C; Figueira I; Almeida AF; McDougall GJ; Stewart D; Yuste JE; Tomás-Barberán FA; Tenreiro S; Outeiro TF; Santos CN
    Sci Rep; 2018 May; 8(1):6965. PubMed ID: 29725038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease.
    Gonçalves SA; Outeiro TF
    Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.
    Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF
    Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.
    Bobela W; Aebischer P; Schneider BL
    Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad proteomics analysis of seeding-induced aggregation of α-synuclein in M83 neurons reveals remodeling of proteostasis mechanisms that might contribute to Parkinson's disease pathogenesis.
    Lumpkin CJ; Patel H; Potts GK; Chaurasia S; Gibilisco L; Srivastava GP; Lee JY; Brown NJ; Amarante P; Williams JD; Karran E; Townsend M; Woods D; Ravikumar B
    Mol Brain; 2024 May; 17(1):26. PubMed ID: 38778381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.
    Ebrahimi-Fakhari D; Saidi LJ; Wahlster L
    Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease.
    Kumar R; Chowdhury S; Ledeen R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
    Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
    Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal attraction - The role of hypoxia when alpha-synuclein gets intimate with mitochondria.
    Burtscher J; Syed MMK; Keller MA; Lashuel HA; Millet GP
    Neurobiol Aging; 2021 Nov; 107():128-141. PubMed ID: 34428721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
    Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.